Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,948 | 43,340 | 46,469 | 58,907 | 7,143 |
| Marketable Securities | 904 | 923 | 1,062 | 887 | 675 |
| Receivables | 1,437 | 1,032 | 1,025 | 703 | 203 |
| Other current assets | 2,953 | 0 | 0 | 0 | 0 |
| TOTAL | $39,143 | $47,591 | $49,995 | $62,824 | $9,226 |
| Non-Current Assets | |||||
| PPE Net | 5,590 | 7,637 | 4,396 | 7,266 | 3,262 |
| Investments And Advances | 0 | 0 | 0 | 0 | 13,417 |
| Intangibles | 80,405 | 111,154 | 117,949 | 57,180 | 24,196 |
| Other Non-Current Assets | 34,425 | 1,959 | 5,042 | 2,035 | 5,318 |
| TOTAL | $120,420 | $120,750 | $127,387 | $66,481 | $46,193 |
| Total Assets | $159,563 | $168,341 | $177,382 | $129,305 | $55,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,810 | 1,198 | 1,088 | 1,092 | 432 |
| Accrued Expenses | 8,652 | 9,893 | 16,450 | 5,264 | 5,752 |
| TOTAL | $14,120 | $13,377 | $19,775 | $9,686 | $8,996 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 178 | 541 | 951 | 1,508 |
| Other Non-Current Liabilities | 80,226 | 55,437 | 54,400 | 12,040 | 11,432 |
| TOTAL | $80,226 | $55,615 | $54,941 | $12,991 | $12,940 |
| Total Liabilities | $94,346 | $68,992 | $74,716 | $22,677 | $21,936 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,612 | 4,612 | 4,579 | 4,491 | 4,446 |
| Common Shares | 252,954 | 251,238 | 240,755 | 234,224 | 157,160 |
| Retained earnings | -187,774 | -151,889 | -138,089 | -127,596 | -123,677 |
| Other shareholders' equity | 37 | 0 | 0 | 0 | 0 |
| TOTAL | $65,217 | $99,349 | $102,666 | $106,628 | $33,483 |
| Total Liabilities And Equity | $159,563 | $168,341 | $177,382 | $129,305 | $55,419 |